Metastatic Breast Cancer

Liver Cancer India,liver Cancer Treatment India,liver Transplant India

Liver Cancer India

Primary liver cancer begins in the cells of the liver itself. Although many cancers are declining in the United States, new cases of primary liver cancer are increasing. Cancers that commonly spread to the liver include colon, lung and breast cancers. These cancers aren’t called liver cancer. Instead, they are named after the organ in which the cancer began – such as metastatic colon cancer to describe cancer that begins in the colon and spreads to the liver. These metastatic cancers are treated based on where the cancer began, rather than being treated as primary liver cancers..

Your liver is a football-sized organ that sits in the upper right portion of your abdomen, beneath your diaphragm and above your stomach. Your liver processes most of the nutrients absorbed from your small intestine and determines how much sugar (glucose), protein and fat enter your bloodstream. It also manufactures blood-clotting substances and certain proteins. Your liver performs a vital detoxifying function by removing drugs, alcohol and other harmful substances from your bloodstream….

In the United States, most cancer found in the liver has spread there from another part of the body. Rather than being referred to as liver cancer, this type of cancer is usually named after the organ where it originated and is described as “metastatic.” For instance, cancer that has spread to the liver from the colon is referred to as metastatic colon cancer….

Please log on to :www.indiahospitaltour.com/cancer-treatment/liver-cancer-treatment-india.html

Send your query : www.indiahospitaltour.com/get-a-quote.html

We Care Core Values

“We have a very simple business model that keeps you as the centre.”

Having the industry’s most elaborate and exclusive Patient Care and Clinical Coordination teams stationed at each partner hospital, we provide you the smoothest and seamless care ever imagined. With a ratio of one Patient Care Manager to five patients our patient care standards are unmatched across the sub continent.

Liver Cancer Treatment In India At Affordable Cost

Liver Cancer

Primary liver cancer begins in the cells of the liver itself. Although many cancers are declining in the United States, new cases of primary liver cancer are increasing.

Cancers that commonly spread to the liver include colon, lung and breast cancers. These cancers aren’t called liver cancer. Instead, they are named after the organ in which the cancer began — such as metastatic colon cancer to describe cancer that begins in the colon and spreads to the liver. These metastatic cancers are treated based on where the cancer began, rather than being treated as primary liver cancers.

Symptoms of Liver Cancer

When symptoms do appear, they may include some or all of the following : -

Loss of appetite and weight Abdominal pain, especially in the upper right part of your abdomen, that may extend into your back and shoulder Nausea and vomiting General weakness and fatigue An enlarged liver Abdominal swelling (ascites) A yellow discoloration of your skin and the whites of your eyes (jaundice)

Causes of Liver Cancer

Your liver is a football-sized organ that sits in the upper right portion of your abdomen, beneath your diaphragm and above your stomach. Your liver processes most of the nutrients absorbed from your small intestine and determines how much sugar (glucose), protein and fat enter your bloodstream. It also manufactures blood-clotting substances and certain proteins. Your liver performs a vital detoxifying function by removing drugs, alcohol and other harmful substances from your bloodstream…

Tests and diagnosis of Liver Cancer

Screening : -

Screening for liver cancer hasn’t been definitively proved to reduce the risk of dying of liver cancer. For this reason, many medical groups don’t recommend liver cancer screening.

However, the American Association for the Study of Liver Diseases recommends liver cancer screening for those thought to have a high risk…

Diagnosis : -

If you experience any of the symptoms of liver cancer, your doctor will ask you about your medical history and perform a physical exam.

Tests and procedures used to diagnose liver cancer include : -

Ultrasound (ultrasonography) : – This test uses sound waves to produce a picture of internal organs, including the liver. Ultrasound is painless and usually takes less than 30 minutes…

Computerized tomography (CT) scan : – This test uses X-rays to produce cross-sectional images of your body. You may also have a variation of the test — known as a CT angiogram — in which contrast dye is injected into an artery in your liver.

Magnetic resonance imaging (MRI) : – MRI creates images using a magnetic field and radio waves. Sometimes a contrast dye also may be used.

Liver biopsy : – In this procedure, a sample of tissue is removed from your liver and examined under a microscope. Liver biopsy is considered the only definitive way to diagnose liver cancer.

Blood tests : – Doctors sometimes use a blood test that checks for the presence of alpha-fetoprotein (AFP) — a type of protein found in small amounts in adults — to detect liver cancer.

Treatments of Liver Cancer

Treatments for primary liver cancer depend on the extent (stage) of the disease as well as your age, overall health, feelings and personal preferences. Discuss all of your options carefully with your treatment team.

The goal of any treatment is to eliminate the cancer completely. When that isn’t possible, the focus may be on preventing the tumor from growing or spreading. In some cases palliative care only is appropriate. Palliative care refers to treatment aimed not at removing or slowing the disease but at helping relieve symptoms and making you as comfortable as possible…

Surgery : – The best treatment for localized resectable cancer is usually an operation known as surgical resection. In some cases, the area of the liver where the cancer is found can be completely removed. You aren’t a candidate for surgical removal of liver tumors if you have cirrhosis or only a small amount of healthy liver tissue. Even when resections are successful, there is a chance the cancer can recur elsewhere in the liver or in other areas within a few years…

Alcohol injection : -In this procedure, pure alcohol is injected directly into tumors, either through the skin or during an operation. Alcohol dries out the cells of the tumor and eventually the cells die. Each treatment consists of one injection, although you may need a series of injections for the best results. Alcohol injection has been shown to improve survival in people with small hepatocellular tumors…

Radiofrequency ablation : – In this procedure, electric current in the radiofrequency range is used to destroy malignant cells. Using an ultrasound or CT scan as a guide, your surgeon inserts several thin needles into small incisions in your abdomen. When the needles reach the tumor, they’re heated with an electric current, destroying the malignant cells. Radiofrequency ablation is an option for people with small, unresectable hepatocellular tumors and for some types of metastatic liver cancers…

Chemoembolization : – Chemoembolization is a type of chemotherapy treatment that supplies strong anti-cancer drugs directly to the liver. Chemoembolization isn’t curative, but it can shrink tumors in a certain percentage of people, which may provide symptom relief and improve survival. During the procedure, the hepatic artery — the artery from which liver cancers derive their blood supply — is blocked, and chemotherapy drugs are injected between the blockage and the liver…

Cryoablation (cryosurgery or cryotherapy) : – This treatment uses extreme cold to destroy cancer cells. Cryoablation may be an option for people with inoperable primary and metastatic liver cancers. It may also be used in addition to surgery, chemotherapy or other standard treatments…

Radiation therapy : – This treatment uses high-powered energy beams to destroy cancer cells and shrink tumors. Radiation may come from a machine outside your body or from radiation-containing materials inserted into your liver. Radiation may be used on its own to treat localized unresectable cancer…

Chemotherapy : – This treatment uses powerful drugs to kill cancer cells. Chemotherapy may be systemic — meaning it travels throughout your body in your bloodstream — or regional. Systemic chemotherapy is generally not effective in treating liver cancer, but may be a treatment option in certain cases…

Liver transplantation : – In this surgical procedure, a diseased liver is removed and replaced with a healthy, donated organ. Liver transplantation may be an option for some people with small, early-stage liver tumors and for certain people with bile duct tumors…

Please log on to : www.indiahospitaltour.com

Send your query : Get a Quote

We Care Core Values

We have a very simple business model that keeps you as the centre.

Having the industry’s most elaborate and exclusive Patient Care and Clinical Coordination teams stationed at each partner hospital, we provide you the smoothest and seamless care ever imagined. With a ratio of one Patient Care Manager to five patients our patient care standards are unmatched across the sub continent.

Liver Cancer Surgery in India at Corporate Cancer Centers of Mumbai and Delhi

Liver Cancer surgery in India for International Oncology patients suffering from Liver problem are traveling all the way to India, for economical Liver surgery and to enjoy pleasant climate, different tourism location. India has become a hub for medical tourists from all around Asia and the rest of the world. Indian hospitals in Bangalore, Hyderabad have some of the best and well qualified surgeons for Liver Cancer surgery in India. Liver cancer surgery comprises various operation of the liver for different disorders. Primary liver cancer begins in the cells of the liver itself. Although many cancers are declining in the western Countries, new cases of primary liver cancer are increasing.
Cancers that commonly spread to the liver include colon, lung and breast cancers. These cancers aren’t called liver cancer. Instead, they are named after the organ in which the cancer began — such as metastatic colon cancer to describe cancer that begins in the colon and spreads to the liver. These metastatic cancers are treated based on where the cancer began, rather than being treated as primary liver cancers….

Stages of primary cancer in children: -

Doctors use the following stages to describe childhood liver cancer : -

* Stage I. At this stage, the cancer can be removed with surgery.
* Stage II. Most stage II liver cancers can be removed with an operation, but microscopic amounts of cancer remain in the liver after surgery…..

Symptoms of Liver Cancer

Most people don’t have signs and symptoms in the early stages of liver cancer, which means the disease may not be detected until it’s quite advanced…..

Causes of Liver Cancer

Your liver is a football-sized organ that sits in the upper right portion of your abdomen, beneath your diaphragm and above your stomach. Your liver processes most of the nutrients absorbed from your small intestine and determines how much sugar (glucose), protein and fat enter your bloodstream. It also manufactures blood-clotting substances and certain proteins. Your liver performs a vital detoxifying function by removing drugs, alcohol and other harmful substances from your bloodstream….

Types include: -

* Hepatocellular carcinoma (HCC) : – This is the most common form of primary liver cancer in both children and adults. It starts in the hepatocytes, the main type of liver cell….

Metastatic cancer: -

In the United States, most cancer found in the liver has spread there from another part of the body. Rather than being referred to as liver cancer, this type of cancer is usually named after the organ where it originated and is described as “metastatic.” For instance, cancer that has spread to the liver from the colon is referred to as metastatic colon cancer….

Risk factors of Liver Cancer

Primary liver cancer can affect people of all ages and races, but certain factors may increase your risk, including: -

1) Sex: – Men are more likely to develop liver cancer than are women, though it isn’t clear why.

2) Age: – In the United States and Europe, liver cancer diagnosis occurs on average at about age 60. People in Asia and Africa tend to be diagnosed with liver cancer at younger ages — between 20 and 50…..

Tests and diagnosis of Liver Cancer

Screening: -

Screening for liver cancer hasn’t been definitively proved to reduce the risk of dying of liver cancer. For this reason, many medical groups don’t recommend liver cancer screening.

However, the American Association for the Study of Liver Diseases recommends liver cancer screening for those thought to have a high risk…..

Diagnosis : -

If you experience any of the symptoms of liver cancer, your doctor will ask you about your medical history and perform a physical exam.

Tests and procedures used to diagnose liver cancer include : -

* Ultrasound (ultrasonography) : – This test uses sound waves to produce a picture of internal organs, including the liver. Ultrasound is painless and usually takes less than 30 minutes. While you lie on a bed or examining table, a wand-shaped device (transducer) is placed on your body. It emits sound waves that are reflected from your liver and transformed into a computer image. Ultrasound provides information about the shape, texture and makeup of tumors…….

Staging : -

Staging tests help determine the size and location of cancer and whether it has spread. Liver cancer may be staged in different ways. One method uses the Roman numerals I through IV, with higher numbers indicating cancers that are more advanced. A stage I tumor is small and confined to one lobe of the liver. By stage IV, several tumors may exist in different lobes, or malignant cells may have spread to other parts of the body.

Treatments of Liver Cancer

Treatments for primary liver cancer depend on the extent (stage) of the disease as well as your age, overall health, feelings and personal preferences. Discuss all of your options carefully with your treatment team……

Treatments for adults with primary liver cancer include : -

* Surgery : – The best treatment for localized resectable cancer is usually an operation known as surgical resection. In some cases, the area of the liver where the cancer is found can be completely removed. You aren’t a candidate for surgical removal of liver tumors if you have cirrhosis or only a small amount of healthy liver tissue. Even when resections are successful, there is a chance the cancer can recur elsewhere in the liver or in other areas within a few years.

Medical tourism India:                                                                                            

A combination of many factors has lead to the recent increase in popularity of medical tourism. Exorbitant cost of healthcare and medical facilities in advanced countries, ease and affordability of international travel, favorable currency exchange rates in the global economy, rapidly improving technology and high standards of medical care in the developing countries has all contributed their share to this rapid development of medical tourism. India has originated as one of the most important hubs for medical tourism. Many people from the developed countries come to India for the rejuvenation promised by yoga and ayurvedic massage however, a nice blend of top-class medical expertise at attractive prices is helping more and more Indian corporate hospitals to lure foreign patients, including patients from developed nations such as the UK and the US, for high end surgeries like Liver Cancer surgeries. Not just cost savings or the high standard of medical care facility, but also the waiting time is much lower for any treatment in India than in any other country. Medical help is often an emergency and situations can turn worse if the treatment is delayed. While you might have to wait for several months to get a surgical operation done in the US, in India things can be arranged within a week. For further details on the low cost Liver Cancer surgery in India visit us at www.indiacancersurgerysite.com  or mail your queries at info@indiacancersurgerysite.com or talk to us international callers, at  +91 9579034639.

Targeting Cancer Stem Cells: Therapeutic Strategies, Drug Development Pipeline, Biomarkers and Diagnostic Opportunities 2010

Cancer Stem Cell (CSC) research has accelerated in the last two years and considerable efforts are now being made to identify drug molecules that selectively target and destroy them. Today, 50 developmental molecules are being evaluated in the hope of targeting this subset of cancer cells. More than 40 companies and commercial groups are progressing these activities and around 20 drug-targeting strategies are being evaluated. Efforts are being made to target CSCs using novel single agents as well as combinations, based on new and established classes. This 2010 report gives a comprehensive update on current therapeutic and diagnostic development in this field, on the drug development pipeline and the most promising research areas in CSC characterisation. New therapeutic and diagnostic opportunities in this field are also presented.

Background: Many cancers contain a subset of stem-like cells believed to play a critical role in the development and progression of the disease. These cells, named Cancer Stem Cells (CSCs), have been found in leukaemia, myeloma, breast, prostate, pancreatic, colon, brain, lung and other cancers. Findings suggest that CSCs are able to “seed” new tumour formation and drive metastasis. CSCs also show resistance to a number of chemotherapy drug classes and radiotherapy – which may explain why it is difficult to completely eradicate cancer cells from the body, and why recurrence remains an ever-present threat. If these findings are confirmed in the clinic, the targeting of CSCs alongside the bulk of other cancer cells will offer a new paradigm in cancer therapeutics. Currently, there are more than 50 CSC R&D programmes in progress, around 50% of which are at Phases I-III. Patient data from the first clinical trials on CSC-targeting drugs are now being reported. More than two thirds of CSC R&D programmes are being taken forward by SME’s, and >90% of the patents in this field have been filed by Universities. Substantial opportunity for collaboration exists in this field, and this has lead to agreements between SMEs and number of international pharmaceutical companies.

Drug Pipeline: Approximately 20 different strategies, which are described in this report, are being pursued in the hope of discovering ways of selectively targeting CSCs. Recently for example, at the CTRC-AACR San Antonio Breast Cancer Symposium in December 2009, data were presented on the targeting of chemotherapy-resistant breast CSCs with the Merck compound MK-0752, a gamma-secretase inhibitor that targets the Notch pathway. In a study involving 35 women with advanced breast cancer, biopsies revealed reduced numbers of breast CSCs. In this particular case, it was suggested that combination therapies involving agents that also target the Notch pathway (believed to be important in CSC renewal) may offer more powerful strategies for killing resistant CSC populations.

Cancer Diagnostics: CSCs are believed to be causally linked to the development and metastatic spread of cancer. If this is confirmed in the clinic, this will place CSCs at the heart of cancer diagnostics and biomarkers. Scientists have identified a number of surface proteins, such as CD44, CD133 and many others, that may have important utility in both of these areas. A number of intracellular markers found in CSCs may also have diagnostic utility. These developments are described in this report. For example, CD133 mRNA levels in peripheral blood, measured using RT-PCR, have been found to predict colon cancer recurrence. There is a need for new methodologies that isolate and characterise circulating tumour cells (CTCs) in the blood, and can be applied to CSCs. CTC technologies using the EpCam marker to isolate these cells are able to predict breast and colon cancer recurrence. The adaption of these techniques, based on specific CSC phenotypes, may provide sensitive new methods for identifying CSCs in the body. If this is achieved, it will have important implications in therapeutic decision-making and monitoring.

This 2010 report gives a comprehensive and up-to-date review of global R&D on CSCs, and strategies to target them. This includes around 40 companies or commercially based research organisations (including 27 SMEs and 8 international pharmaceutical companies) that are progressing drug discovery activities, including drug pipeline (pre-clinical to Phase III), discovery strategy, candidate molecules, drug targets, clinical trials and related areas.

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3358/Targeting-Cancer-Stem-Cells-Therapeutic-Strategies-Drug-Development-Pipeline-Biomarkers-and-Diagnostic-Opportunities-2010.html

or email us your query at :

Cancer Stem Cell (CSC) research has accelerated in the last two years and considerable efforts are now being made to identify drug molecules that selectively target and destroy them. Today, 50 developmental molecules are being evaluated in the hope of targeting this subset of cancer cells. More than 40 companies and commercial groups are progressing these activities and around 20 drug-targeting strategies are being evaluated. Efforts are being made to target CSCs using novel single agents as well as combinations, based on new and established classes. This 2010 report gives a comprehensive update on current therapeutic and diagnostic development in this field, on the drug development pipeline and the most promising research areas in CSC characterisation. New therapeutic and diagnostic opportunities in this field are also presented.

Background: Many cancers contain a subset of stem-like cells believed to play a critical role in the development and progression of the disease. These cells, named Cancer Stem Cells (CSCs), have been found in leukaemia, myeloma, breast, prostate, pancreatic, colon, brain, lung and other cancers. Findings suggest that CSCs are able to “seed” new tumour formation and drive metastasis. CSCs also show resistance to a number of chemotherapy drug classes and radiotherapy – which may explain why it is difficult to completely eradicate cancer cells from the body, and why recurrence remains an ever-present threat. If these findings are confirmed in the clinic, the targeting of CSCs alongside the bulk of other cancer cells will offer a new paradigm in cancer therapeutics. Currently, there are more than 50 CSC R&D programmes in progress, around 50% of which are at Phases I-III. Patient data from the first clinical trials on CSC-targeting drugs are now being reported. More than two thirds of CSC R&D programmes are being taken forward by SME’s, and >90% of the patents in this field have been filed by Universities. Substantial opportunity for collaboration exists in this field, and this has lead to agreements between SMEs and number of international pharmaceutical companies.

Drug Pipeline: Approximately 20 different strategies, which are described in this report, are being pursued in the hope of discovering ways of selectively targeting CSCs. Recently for example, at the CTRC-AACR San Antonio Breast Cancer Symposium in December 2009, data were presented on the targeting of chemotherapy-resistant breast CSCs with the Merck compound MK-0752, a gamma-secretase inhibitor that targets the Notch pathway. In a study involving 35 women with advanced breast cancer, biopsies revealed reduced numbers of breast CSCs. In this particular case, it was suggested that combination therapies involving agents that also target the Notch pathway (believed to be important in CSC renewal) may offer more powerful strategies for killing resistant CSC populations.

Cancer Diagnostics: CSCs are believed to be causally linked to the development and metastatic spread of cancer. If this is confirmed in the clinic, this will place CSCs at the heart of cancer diagnostics and biomarkers. Scientists have identified a number of surface proteins, such as CD44, CD133 and many others, that may have important utility in both of these areas. A number of intracellular markers found in CSCs may also have diagnostic utility. These developments are described in this report. For example, CD133 mRNA levels in peripheral blood, measured using RT-PCR, have been found to predict colon cancer recurrence. There is a need for new methodologies that isolate and characterise circulating tumour cells (CTCs) in the blood, and can be applied to CSCs. CTC technologies using the EpCam marker to isolate these cells are able to predict breast and colon cancer recurrence. The adaption of these techniques, based on specific CSC phenotypes, may provide sensitive new methods for identifying CSCs in the body. If this is achieved, it will have important implications in therapeutic decision-making and monitoring.

This 2010 report gives a comprehensive and up-to-date review of global R&D on CSCs, and strategies to target them. This includes around 40 companies or commercially based research organisations (including 27 SMEs and 8 international pharmaceutical companies) that are progressing drug discovery activities, including drug pipeline (pre-clinical to Phase III), discovery strategy, candidate molecules, drug targets, clinical trials and related areas.

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3358/Targeting-Cancer-Stem-Cells-Therapeutic-Strategies-Drug-Development-Pipeline-Biomarkers-and-Diagnostic-Opportunities-2010.html

or email us your query at : info@visionshopsters.com
———————————————-

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease
Genzyme Corporation announced today that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood. The results have been pre-published on the journal’s website and are available to subscribers.

Read more on News-Medical-Net

Insidermedicine in 60 – February 13, 2008

From Indiana – Artificial sweeteners may actually increase weight gain and raise the risk of developing adipose tissue. Researchers observed the effects of giving 9 rats yogurt with artificial sweetener and compared it to 8 rats who were given yogurt with table sugar. Rats who ingested the artificial sweetener consumed more calories, gained more weight, and gained more body fat. From California – Avastin has shown promise for the treatment of metastatic breast cancer, when used in combination with chemotherapy. In a randomized clinical trial of over 700 women with metastatic HER-2 negative breast cancer, those who received Avastin in conjunction to docetaxel had a longer progression-free survival rate than those who received chemotherapy alone. The FDA decision on whether to add breast cancer to the list of Avastin indications is expected later this month. And finally, from Germany – Drug-eluting stents, commonly used in advanced heart disease, may also benefit patients with severe peripheral vascular disease. In a randomized clinical trial of 154 patients, those who received a stent which released Paclitaxel were less likely to have narrowed arteries and less likely to have restenosis following the procedure. For Insidermedicine in 60, I’m Dr. Susan Sharma.

Vaccine Proves to be Efficient in Treating Prostate Cancer

Since in US, more than 200,000 new cases of prostate cancer are discovered every year a more effective treatment was desperately needed.

At the prostate cancer symposium in Orlando, co-sponsored by the American Society of Clinical Oncology, Eric J. Small, MD, UCSF professor of medicine and urology presented the findings of the study he led helped by other 19 US institutions, regarding an effective treatment for prostate cancer.

Scientists said that the rate of survival increased by four and a half months in those who were administered the cancer vaccine compared with those who got the placebo.

For the patients this is great news because it gives them hope that an even better vaccine could be discovered. This vaccine is not like the others that are designed to prevent a disease. This is made to treat advanced prostate cancer by increasing the immune system’s response to cancer cells.

The vaccine was well tolerated by patients and the side effects were mild: fever and chills. This is good news because chemotherapy and radiation gives a lot of unbearable side effects.

Small included in the study 127 patients suffering of asymptomatic metastatic hormone refractory prostate cancer (HRPC). 82 of them received the vaccine and 45 got placebo. They were administered three shots over six weeks. The treatment continued three years.

For those treated with the vaccine, the median rate of survival was 25.9 months. For those who got a placebo treatment, the overall of survival was 21.4 months.

The conclusions were that 115 patients of this group had progressive disease at the time of data analysis and all patients were followed for survival for 3 years.

Scientists do not know if the vaccine will work on patients suffering of early-stage prostate cancer and of explosive terminal cancer. The vaccine, called Provenge, does not cure cancer but at least it slows it down.

Other cancer vaccines are being developed for treating: leukemia, breast cancer, colon cancer, and kidney and pancreas cancer as well.

The human body is not able to recognize the cancer cells and that is why it can not fight them without help. The vaccine is designed to alert the body is cancerous cells are present. Provenge has been made out of a genetically engineered protein and a dendritic cell provided from the patient’s bloodstream. After getting the vaccine shots, the immune system will react and will activate immune T-cells to find and destroy the cancer cells.

This discovery is important not only for those who suffer of the disease but also for the field. This vaccine confirms what everybody denied, that vaccines can really work.

For more information about prostate cancer and about prostate cancer treatment please review this web site http://www.prostate-cancer-center.com

Is Brain Cancer Dreadful

Everyone fears the word cancer. However most types of cancers can be beaten, if you catch it up soon enough, and even if you dont there are new treatments coming out by the minute everyday that will help you fight and successfully beat cancer. There are however some types of cancers that are more complex in nature than others, brain cancer is the one we’re speaking of and the one we will be focusing on.

Two types of known brain cancer exist, namely: Primary brain cancer (these generally initiate in the brain), Primary brain cancer almost never moves to any other part of the body, so death is brought on by uncontrollable tumor growth within the brain cavity. Then you get metastatic brain cancer or otherwise known as secondary brain cancer (this type of cancer originates in other parts of the body and get transported or should we say it migrates to the brain thus causing the person to circum to secondary brain cancer.

In some cases the patient will not know they have cancer until its too late, so know what symptoms to look out for is vital when it comes to any type tumor or cancer.

However, before we go there, let’s take a look at the known causes of brain cancer. The main known cause of such type of cancer is the continuous contact with vinyl chloride. Then there are things like pipes, car parts, furniture, wire coatings, and other house wares that contain a substance called carcinogen. Patients who suffer from a long standing battle with melanoma, colon cancer, breast cancer, kidney cancer, and lung cancer are all at risk of being or getting secondary brain cancer.

If you think that you might have cancer here are some things to look out for, be sure to do a check regularly and please get yourself to a doctor for a detailed check at least once every three months (or as directed by your doctor). A brain tumor has the tendency to obstruct the flow or the brains cerebral fluids, or cerebrosinal fluid (this have the devastating result of the buildup hydrocephalus and can thus increase intercranial pressure, which leads to vomiting, nausea and sever headaches.

Brain cancer also leads to impaired judgment, memory loss, reduced mind capacity, vision loss; sever behavior changes, swelling of the optic nerve and impaired smell sense. If you suffer from any of these get yourself to a trained doctor immediately.

Making Memories foundation :Fitness – Feeling Sexy Dancing with Divas for Breast Cancer

www.fimbwellness.com carla mock Divas www.divasdancingfordivas.com ABOUT THE MAKING MEMORIES BREAST CANCER FOUNDATION Their mission is to grant wishes, including memory-making events, for metastatic breast cancer patients, while continuing to support, educate and increase resource awareness Fimb Wellness Center is proud to help support the Making Memories Foundation. In an effort to support their mission the Inaugural Divas Dancing for Divas CONTACT INFORMATION Fimb Wellness Center www.fimbwellness.com 862 SW Blue Parkway Lees Summit Missouri 64063 (816) 260-6993 Divas Dancing for Divas www.divasdancingfordivas. mrs missouri heather chatlos Think Pink

PocockM.jpg

Image taken on 2009-08-04 09:39:44 by michael_swan.